2019 Á¦ 21ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¾ö : 2019-09-01±³À°ÀÏÀÚ : 2019-09-01
±³À°Àå¼Ò : ¼¿ïµå·¡°ï½ÃƼ ÇѶó·ë
±³À°ÁÖÁ¦ :
2019 Á¦ 21ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Åõ¼®Àü¹®ÀÇ ¿¬±¸È¸
´ã´çÀÚ : ±ÇÇöÁ¤
¿¬¶ôó : 02-521-0458
À̸ÞÀÏ :
office@e-kda.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í »çÀüµî·Ï (ÀÇ»ç: 5¸¸¿ø / °£È£»ç: 4¸¸¿ø) ÇöÀåµî·Ï (ÀÇ»ç:6¸¸¿ø / °£È£»ç 5¸¸¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 09:00~09:25 History of dialysis modality ±è¹®Àç(³ª»ç·¿ ±¹Á¦º´¿ø)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 09:25~09:50 Pre vs. post vs. mixed dilutional HDF ¹ÚºÀ¼ö(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 09:50~10:15 Is expanded hemodialysis an alternative to HDF? ÀÌâÈ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 10:45~11:20 AI ÃÖÀ±¼·(DHP)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 11:20~12:00 Health care ¹®¿©Á¤(IMM investment)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 12:00~13:00 HCV treatment on CKD patients : In DAA era Àü´ë¿ø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 13:00~13:25 What nephrologists must know in treatment of latent tuberculosis? ±èÇý·Ã(¿øÀڷº´¿ø)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 13:25~13:50 Hyperglycemia manage ±èµµÇü(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 13:50~14:15 Hyperkalemia manage ÃÖ¹ü¼ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 14:15~14:40 Anemia manage ½ÅÁ¤È£(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 15:00~15:15 Case I ¹®ÁöÀÎ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 15:15~15:30 Case II ±èö¼ö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 09-01 3Ãþ, ÇѶó·ë 15:30~15:45 Case III ¹ÚÀÍÇö(¸íÁöº´¿ø)
Åä·Ð 09-01 3Ãþ, ÇѶó·ë 15:45~15:55 ÅäÀÇ ()